Your browser doesn't support javascript.
loading
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Coombes, R C; Howell, Sacha; Lord, Simon R; Kenny, Laura; Mansi, Janine; Mitri, Zahi; Palmieri, Carlo; Chap, Linnea I; Richards, Paul; Gradishar, William; Sardesai, Sagar; Melear, Jason; O'Shaughnessy, Joyce; Ward, Patrick; Chalasani, Pavani; Arkenau, Tobias; Baird, Richard D; Jeselsohn, Rinath; Ali, Simak; Clack, Glen; Bahl, Ashwani; McIntosh, Stuart; Krebs, Matthew G.
Afiliação
  • Coombes RC; Imperial College, South Kensington, London, UK.
  • Howell S; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Lord SR; Early Phase Clinical Trials Unit, Department of Oncology, University of Oxford, Oxford, UK.
  • Kenny L; Imperial College, South Kensington, London, UK.
  • Mansi J; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Mitri Z; OHSU Knight Cancer Institute, Portland, OR, USA.
  • Palmieri C; University of Liverpool, Liverpool, UK.
  • Chap LI; University of California, Los Angeles, CA, USA.
  • Richards P; Blue Ridge Cancer Center, Salem, VA, USA.
  • Gradishar W; Northwestern University, Chicago, IL, USA.
  • Sardesai S; US Oncology Research, OHC, Cincinnati, OH, USA.
  • Melear J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA.
  • O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA.
  • Ward P; US Oncology Research, OHC, Cincinnati, OH, USA.
  • Chalasani P; University of Arizona Cancer Center, Tucson, AZ, USA.
  • Arkenau T; Sarah Cannon Research Institute, London, UK.
  • Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Jeselsohn R; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ali S; Imperial College, South Kensington, London, UK.
  • Clack G; Carrick Therapeutics, Dublin, Ireland.
  • Bahl A; Carrick Therapeutics, Dublin, Ireland.
  • McIntosh S; Carrick Therapeutics, Dublin, Ireland.
  • Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. matthew.krebs@manchester.ac.uk.
Nat Commun ; 14(1): 4741, 2023 Aug 07.
Article em En | MEDLINE | ID: mdl-37550302
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article